P03-314 - Depression and sleep disorders in progressed glaucoma: an indication for melatonergic antidepressants?

@inproceedings{Agorastos2010P03314D,
  title={P03-314 - Depression and sleep disorders in progressed glaucoma: an indication for melatonergic antidepressants?},
  author={Agorastos Agorastos and Christos Skevas and Mario Matthaei and Christian G Huber},
  year={2010}
}
Introduction Glaucoma is a chronic, progressive optic neuropathy, with visual field defects (VFD) and progressive loss of the retinal ganglion cells, leading herewith to an affected light transmission to the suprachiasmatic nuclei. Progressed glaucoma has been therefore lately suggested to lead to a circadian misalignment and thus to several physiological consequences, including sleep and affective disorders. Objectives The investigation of depressive symptoms and sleep disorders among glaucoma… CONTINUE READING